...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Next question
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Analyst Research and Ratings

RVX has underperformed its Biotechnology & Drugs peers over the last three months and over the past year too. ((And over the last 5 years,,,!!!!))

Morningstar’s Take

More information about Morningstar's Take.
Morningstar’s Take
Morningstar Rating
(Backward-looking)
 3 stars out of 5 starsQ
Quantitative Valuation Under Valued
Fair ValueQ 0.11 CAD
Last price as of
Apr 02, 2024		 -- CAD
Quantitative Uncertainty Extreme
Economic Moat --
Market Cap 15.0 M
Country of Domicile Canada

Trading Central

 Over Valued

Rate of Return Estimate: -- More information about Rate of Return Estimate.

Short-Term Sentiment More information about Short-Term Sentiment.
 
Recent bearish events outweigh bullish events. Strong Bearish EvidenceRecent bearish events outweigh bullish events.
Intermediate-Term Sentiment More information about Intermediate-Term Sentiment.
 
The bullish and bearish events are balanced. Neutral EvidenceThe bullish and bearish events are balanced.
Long-Term Sentiment More information about Long-Term Sentiment.
 
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply